In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular ...

In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that help the blood clot was ...

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least ...

Results show noninferiority to a full dose in preventing a recurrence of blood clots and an advantage when it comes to ...

Damian Lillard has no timeline to return to the Milwaukee Bucks after being diagnosed with deep vein thrombosis in his right ...

Even a small warning stroke—known as a transient ischemic attack (TIA) or a minor stroke—can leave a person at high risk for ...

Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia (fitusiran), the first ...

Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...

The risk of a full-blown stroke will remain high for at least a decade after a person has a slight brush with stroke, in the ...

FRIDAY, March 28, 2025 (HealthDay News) -- The risk of a full-blown stroke will remain high for at least a decade after a ...

SonoVascular, Inc. recently announced it has successfully completed an initial set of eight cases in patients with deep vein thro ...

The signs of a dangerous blood clot can vary depending on its location. Some people may also not experience any symptoms.